Navigation Links
Combating cancer's double whammy
Date:11/11/2010

It can be fatal if the clot breaks away and lodges in the lung (pulmonary embolism). The aim of this analysis of primary care data is to establish a clearer picture of the increased risk of venous thromboembolism in different cancers, and to help create bespoke guidelines for doctors in how to prevent the condition arising after a cancer diagnosis.

The three year study is being carried out in the University's Division of Epidemiology and Public Health. Researchers believe that some 3,000 deaths a year in cancer patients from VTE could potentially be prevented using cheap and safe preventative treatments known as thromboprophylaxis when targeted at the most appropriate times; the most widely used are warfarin and heparin.

The researchers will use three UK health databases to analyse information from 100,000 cancer patients between 2001 and 2009 and compare these cases with a random sample of 500,000 people without cancer. All the data collected from the General Practice Research Database, the Hospital Episode Statistics database and Cancer Registries, will be anonymous.

Lead researcher and epidemiologist, Dr Matthew Grainge, said: "We know that cancer can trigger clotting in the venous system and cancer treatments like surgery and chemotherapy can increase this risk further. This detailed analysis will show us more precisely when people with cancer are at greatest risk of venous thromboembolism compared with the general population within periods defined by cancer treatment, time since diagnosis and hospitalisation. We will also be comparing occurrence and risks in over 20 different types of cancer."

Clinical Associate Professor in the Department of Community Health Sciences, Joe West, said: "At the moment there is little clear guidance for clinicians on preventative treatment for this dangerous condition which is more prevalent among cancer patients. Epidemiological studies like this are vital in the fight to cut the number of preventable deaths in this group of patients who are already suffering from cancer and enduring the effects of its treatment."


'/>"/>

Contact: Emma Rayner
emma.rayner@nottingham.ac.uk
44-115-951-5793
University of Nottingham
Source:Eurekalert

Related medicine news :

1. Holistic Management and Allan Savory Win the 2010 Buckminster Fuller Award for Turning Deserts into Thriving Grasslands and Combating Climate Change.
2. Texas Center for Cancer Nanomedicine targets 2 tough cancers
3. New Drug Shows Promise Against Certain Lung Cancers
4. Tumor suppressor acts as oncogene in some cancers, say Mayo Clinic researchers
5. Surprise finding: Pancreatic cancers progress to lethal stage slowly
6. Healthy Living Can Prevent Nearly 25% of Colorectal Cancers
7. New Finding Suggests Safe Surgical Margins When Removing Breast Cancers
8. Duke vaccine extends survival for patients with deadly brain cancers
9. New device for identifying aggressive breast cancers
10. A revolutionary new way of reversing certain cancers
11. Radiation exposure poses similar risk of first and second cancers in atomic bomb survivors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... (PRWEB) , ... January 17, 2017 , ... Livionex, Inc., ... results of a double blind clinical study for its dental gel that shows significant ... national brand of toothpaste containing triclosan. The study was conducted at the Beckman Laser ...
(Date:1/17/2017)... ... January 17, 2017 , ... Physicians ... Sandra Lee as keynote speaker for the 34th Annual Miami Breast Cancer Conference®, ... the announcement, PER® president, Phil Talamo, said, “We are delighted to have Sandra ...
(Date:1/17/2017)... ... January 17, 2017 , ... Lynx Technology Partners ... top US security companies for consecutive years, today announced the appointment of four ... independent board nomination process to a close and positions Lynx for even faster ...
(Date:1/17/2017)... ... January 17, 2017 , ... Today, FloSports , a global leader ... new agreement as part of a long-term extension of their media partnership. The partnership, ... of some of the sport’s premier events exclusively on FloWrestling.com as well as usage ...
(Date:1/16/2017)... (PRWEB) , ... January 17, 2017 , ... ... Au Bon Pain, an internationally recognized leader in the fast-casual category, announces a ... such as the Good Egg Breakfast Sandwich, Turkey Mash-Up Sandwich, Cranberry Crunch & ...
Breaking Medicine News(10 mins):
(Date:1/17/2017)... , Jan. 17, 2017  Edwards Lifesciences Corporation ... patient-focused innovations for structural heart disease and critical care ... quarter ended December 31, 2016 after the market closes ... conference call at 5:00 p.m. ET that day to ... conference call, dial (877) 407-8037 or (201) 689-8037.  For ...
(Date:1/17/2017)... KANSAS CITY, Mo. , Jan. 17, 2017 ... selected Velos and its flagship technology platform Velos ... initiatives. CHNC is a benchmarking and ... Care Units at leading children,s hospitals across ... a benchmark of care and short-term outcomes for ...
(Date:1/17/2017)... , January 17, 2017 ReportsnReports.com adds ... report provides an overview of the Anaphylaxis,s therapeutic pipeline with ... comparative analysis at various stages, therapeutics assessment by drug target, ... type, along with latest updates, and featured news and press ... ...
Breaking Medicine Technology: